New evidence indicates that COVID-19 increases the risk of VTE. In a study of 184 patients with COVID-19, researchers documented 75 thrombotic events, primarily pulmonary embolism (PE). This “very high” rate aligns with other studies following coronavirus patients, the researchers note in Thrombosis Research.
Likewise, research has linked COVID-19 to increased rates of stroke, even in young, otherwise healthy patients. While recovering, immobile stroke patients risk DVT — but there is also some good news. A randomized, clinical trial of 2,876 such patients found that intermittent pneumatic compression (IPC) can markedly reduce the risk of DVT. Writing in the Lancet, researchers concluded that IPC reduced proximal DVTs by nearly a third (29.9%). Additionally, researchers concluded that IPC may improve patient survival.
With U.S. COVID-19 infections numbering in the millions and growing, the potential risk and the need to properly guard against VTE is significant and expanding.